Abiopharma

Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference

Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program

Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates via Webcast

Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies

Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair

(30% Negative) AngioDynamics, Inc. (ANGO) Reports Q1 2026 Financial Results

Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies

(70% Positive) Aclaris Therapeutics, Inc. (ACRS) Provides Update on Expected for immuno-inflammatory diseases

Alvotech announces planned CEO succession and leadership transition

Alvotech tilkynnir breytingar á yfirstjórn félagsins

Alvotech announces planned CEO succession and leadership transition

Evotec SE (EVOTF) Files Form 6-K

(85% Positive) Alkermes plc. (ALKS) Announces Clinical Development Update

(86% Positive) Fractyl Health, Inc. (GUTS) Announces Clinical Development Update

Cartesian Therapeutics Announces New Employment Inducement Grants